SCHEMBL4492945

SCHEMBL4492945

CCNCCN(c1ccc(NC(=C2C(=O)Nc3cc(Cl)ccc32)c2ccccc2)cc1)S(C)(=O)=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.36
KDR P35968 4/20 0.34
PRKAA2 P54646 1/20 0.34
PRKAA1 Q13131 1/20 0.34
PDGFRB P09619 2/20 0.34
KIT P10721 2/20 0.34
KMT2A Q03164 5/20 0.33
MEN1 O00255 4/20 0.33
LRRK2 Q5S007 2/20 0.33
TSHR P16473 1/20 0.33
CES1 P23141 1/20 0.33
EGFR P00533 1/20 0.33
FGFR1 P11362 1/20 0.33
NEK2 P51955 1/20 0.33
MELK Q14680 1/20 0.33
FLT4 P35916 1/20 0.33
FLT3 P36888 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HTT P42858 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4492940 1.00 GAA (0.36) GAAKDRPRKAA2PRKAA1PDGFRB
SCHEMBL6321650 0.90 IDO1 (0.35) GAAKDRPRKAA2PRKAA1PDGFRB
SCHEMBL6321653 0.90 IDO1 (0.35) GAAKDRPRKAA2PRKAA1PDGFRB
SCHEMBL4490565 0.89 KDR (0.38) GAAKDRPRKAA2PRKAA1PDGFRB
SCHEMBL4490568 0.89 KDR (0.38) GAAKDRPRKAA2PRKAA1PDGFRB
SCHEMBL4494272 0.89 GAA (0.38) GAAKMT2AMEN1TSHRCES1
SCHEMBL4494278 0.89 GAA (0.38) GAAKMT2AMEN1TSHRCES1
SCHEMBL479708 0.88 POLB (0.40) KDRPDGFRBKITKMT2AMEN1
SCHEMBL479706 0.88 POLB (0.40) KDRPDGFRBKITKMT2AMEN1
SCHEMBL479704 0.88 POLB (0.40) KDRPDGFRBKITKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514468-B2 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-04-07 US disclosed
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions KDR, FLT1, EGFR GAA 4394/4885KDR 1/4885PRKAA2 2282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.